Krsnaa Diagnostics Limited (KRSNAA.BO)
INR 909.8
(-1.02%)
INR 909.8
(-1.02%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 223.21 Million | 763.01 Million | 1.28 Billion | 1.02 Billion | 378.09 Million | 582.66 Million |
| Net Income | 568.37 Million | 802.01 Million | 865.1 Million | 2.95 Billion | -1.58 Billion | -777.26 Million |
| Depreciation & Amortization | 745.47 Million | 537.82 Million | 413.87 Million | 374.39 Million | 323.32 Million | 255.61 Million |
| Deferred income taxes | - | -140.26 Million | -55.51 Million | -2.59 Billion | - | - |
| Stock-based compensation | 9.01 Million | 6.73 Million | 12.42 Million | 8.2 Million | - | - |
| Change in working capital | -967.79 Million | -355.76 Million | -6.61 Million | 148.34 Million | -193.18 Million | 33.69 Million |
| Other non-cash items | 2.35 Billion | -87.53 Million | 54.97 Million | 140.02 Million | 1.83 Billion | 1.07 Billion |
| Investing Cash Flow | -1.39 Billion | -1.08 Billion | -2.4 Billion | -611.39 Million | -766.48 Million | -1.99 Billion |
| Investments in PPE | -1.93 Billion | -1.41 Billion | -1.32 Billion | -668.4 Million | -767.49 Million | -997.77 Million |
| Acquisitions | 8.87 Million | 66.34 Million | 10.9 Million | 20 Million | - | - |
| Investment purchases | - | - | -1.26 Billion | -56.97 Million | -72.78 Million | -1 Billion |
| Sales/Maturities of investments | 537.4 Million | 156.92 Million | - | - | - | - |
| Other Investing Activities | 650.1 Million | 101.45 Million | 169.5 Million | 93.98 Million | 73.79 Million | 14.73 Million |
| Financing Cash Flow | 965.94 Million | -331.45 Million | 1.75 Billion | 308.4 Million | 57.77 Million | 1.24 Billion |
| Debt repayment | -902.21 Million | -91.3 Million | -1.59 Billion | -555.27 Million | -302.49 Million | -441.5 Million |
| Dividends payments | -86.29 Million | -78.49 Million | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 231.92 Million | -68.5 Million | 4 Billion | 7.31 Million | -570 Thousand | 959.64 Million |
| Other Financing Activities | 1.06 Billion | -93.16 Million | -645.79 Million | 856.36 Million | 360.83 Million | 724.57 Million |
| Accounts receivables | -1.03 Billion | -144.31 Million | 160.33 Million | -110.42 Million | -76.93 Million | -294.98 Million |
| Accounts payables | 156.69 Million | -167.29 Million | -60.04 Million | 404.62 Million | -36.38 Million | 256.52 Million |
| Inventory | -107.33 Million | -159.04 Million | -19.61 Million | -21.43 Million | -8.54 Million | -22.62 Million |
| Other working capital | 18.34 Million | 114.88 Million | -87.29 Million | -124.43 Million | -71.33 Million | 94.76 Million |
| Cash at beginning of period | 227.2 Million | 884.53 Million | 246.75 Million | -475.84 Million | -145.22 Million | 21.93 Million |
| Cash at end of period | 535.45 Million | 227.2 Million | 884.53 Million | 246.75 Million | -475.84 Million | -145.22 Million |
| Capital Expenditure | -1.93 Billion | -1.41 Billion | -1.32 Billion | -668.4 Million | -767.49 Million | -997.77 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 308.25 Million | -657.33 Million | 637.78 Million | 722.59 Million | -330.62 Million | -167.15 Million |
| Free Cash Flow | -1.71 Billion | -650.59 Million | -37.95 Million | 357.18 Million | -389.4 Million | -415.11 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 179.21 Million | 187.27 Million | 568.37 Million | 129.74 Million | 104.96 Million | 146.43 Million |
| Depreciation & Amortization | - | - | 745.47 Million | 212.31 Million | 194.64 Million | 157.35 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | 9.01 Million | - | - | - |
| Change in working capital | - | - | -967.79 Million | - | - | - |
| Other non-cash items | -179.21 Million | -187.27 Million | 2.35 Billion | -129.74 Million | -104.96 Million | -146.43 Million |
| Investing Cash Flow | - | - | -1.39 Billion | - | - | - |
| Investments in PPE | - | - | -1.93 Billion | - | - | - |
| Acquisitions | - | - | 8.87 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 537.4 Million | - | - | - |
| Other Investing Activities | - | - | 650.1 Million | - | - | - |
| Financing Cash Flow | - | - | 965.94 Million | - | - | - |
| Debt repayment | - | - | -902.21 Million | - | - | - |
| Dividends payments | - | - | -86.29 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 231.92 Million | - | - | - |
| Other Financing Activities | - | - | 1.06 Billion | - | - | - |
| Accounts receivables | - | - | -1.03 Billion | - | - | - |
| Accounts payables | - | - | 156.69 Million | - | - | - |
| Inventory | - | - | -107.33 Million | - | - | - |
| Other working capital | - | - | 18.34 Million | - | - | - |
| Cash at beginning of period | - | - | 227.2 Million | 303.22 Million | 198.26 Million | 227.2 Million |
| Cash at end of period | - | - | 535.45 Million | 727.83 Million | 303.22 Million | 146.43 Million |
| Capital Expenditure | - | - | -1.93 Billion | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 308.25 Million | 424.61 Million | 104.96 Million | -80.77 Million |
| Free Cash Flow | - | - | -1.71 Billion | 424.61 Million | 104.96 Million | 146.43 Million |
GNSS
300843
SHRG
3152
9028
PODDARHOUS